Key facts
- A new pill for sleep apnea has shown promising results in early trials.
- The pill could offer an alternative to CPAP machines.
- Untreated sleep apnea increases the risk of cardiovascular disease and Type 2 diabetes.
A novel pill designed to treat obstructive sleep apnea has yielded promising results in early trials. This development could offer a more comfortable alternative to the widely used CPAP (continuous positive airway pressure) machines, which many patients find cumbersome. Obstructive sleep apnea, if left untreated, is associated with a higher risk of developing serious health conditions such as cardiovascular disease and Type 2 diabetes.